Ascentage Pharma Group International (NASDAQ:AAPG) Shares Up 1.7% – Here’s What Happened

Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) shares shot up 1.7% on Wednesday . The stock traded as high as $47.20 and last traded at $47.20. 15,299 shares were traded during trading, an increase of 106% from the average session volume of 7,422 shares. The stock had previously closed at $46.40.

Ascentage Pharma Group International Trading Up 1.7%

The business’s 50-day moving average price is $39.53. The company has a debt-to-equity ratio of 3.24, a quick ratio of 1.26 and a current ratio of 1.26.

Hedge Funds Weigh In On Ascentage Pharma Group International

Several institutional investors have recently added to or reduced their stakes in AAPG. Monashee Investment Management LLC bought a new position in Ascentage Pharma Group International during the first quarter valued at about $3,511,000. Chevy Chase Trust Holdings LLC bought a new position in Ascentage Pharma Group International during the second quarter valued at about $227,000. Hsbc Holdings PLC bought a new position in Ascentage Pharma Group International during the second quarter valued at about $391,000. Finally, Tema Etfs LLC bought a new position in Ascentage Pharma Group International during the second quarter valued at about $610,000.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.